Broadleaf Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.96M | Sell |
6,365
-25
| -0.4% | -$19.5K | 1.09% | 31 |
|
|
2025
Q1 | $5.28M | Sell |
6,390
-7,204
| -53% | -$5.95M | 1.38% | 25 |
|
|
2024
Q4 | $10.5M | Sell |
13,594
-5,104
| -27% | -$3.94M | 2.45% | 16 |
|
|
2024
Q3 | $16.6M | Sell |
18,698
-50
| -0.3% | -$44.3K | 3.92% | 6 |
|
|
2024
Q2 | $17M | Sell |
18,748
-71
| -0.4% | -$64.3K | 4.11% | 6 |
|
|
2024
Q1 | $14.6M | Buy |
18,819
+3,848
| +26% | +$2.99M | 3.75% | 6 |
|
|
2023
Q4 | $8.73M | Sell |
14,971
-4,677
| -24% | -$2.73M | 2.56% | 14 |
|
|
2023
Q3 | $10.6M | Sell |
19,648
-51
| -0.3% | -$27.4K | 3.52% | 8 |
|
|
2023
Q2 | $9.24M | Buy |
19,699
+31
| +0.2% | +$14.5K | 3.01% | 7 |
|
|
2023
Q1 | $6.75M | Buy |
19,668
+479
| +2% | +$164K | 2.41% | 19 |
|
|
2022
Q4 | $7.02M | Buy |
+19,189
| New | +$7.02M | 2.77% | 15 |
|